Stock Earnings

Question 1

What are Hangzhou Tigermed Consulting Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Hangzhou Tigermed Consulting Co Ltd has a total asset of $28,671, Net profit of $405

Question 2

What are the key financial ratios for HNGZY?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd's Current ratio is 3.58, has a Net margin is 6.13, sales per share of $7.65.

Question 3

How is Hangzhou Tigermed Consulting Co Ltd's revenue broken down by segment or geography?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd largest revenue segment is Clinical Trial Technical Services, at a revenue of 4,168,128,309 in the most earnings release.For geography, China is the primary market for Hangzhou Tigermed Consulting Co Ltd, at a revenue of 4,234,516,020.

Question 4

Is Hangzhou Tigermed Consulting Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Hangzhou Tigermed Consulting Co Ltd has a net profit of $405

Question 5

Does Hangzhou Tigermed Consulting Co Ltd have any liabilities?

Accepted Answer

yes, Hangzhou Tigermed Consulting Co Ltd has liability of 8,000

Question 6

How many outstanding shares for Hangzhou Tigermed Consulting Co Ltd?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd has a total outstanding shares of 861.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6,561	6,603	7,384	7,085	5,213	3,192
Revenue Growth (YoY)	-4%	-11%	4%	36%	63%	14%
Cost of Revenue	4,855	4,358	4,538	4,277	2,942	1,678
Gross Profit	1,706	2,244	2,845	2,808	2,270	1,514
Selling, General & Admin	965	860	782	722	652	435
Research & Development	257	229	254	229	211	151
Operating Expenses	1,174	1,154	1,132	1,028	841	557
Other Non Operating Income (Expenses)	-8	0	1	2	-12	-4
Pretax Income	800	664	2,488	2,585	3,684	2,218
Income Tax Expense	163	216	338	313	292	189
Net Income	612	405	2,024	2,006	2,874	1,749
Net Income Growth	-36%	-80%	1%	-30%	64%	108%
Shares Outstanding (Diluted)	868.8	863.04	865.32	864.89	870.95	799
Shares Change (YoY)	0%	0%	0%	-1%	9%	7%
EPS (Diluted)	0.7	0.46	2.34	2.32	3.3	2.19
EPS Growth	-36%	-80%	1%	-30%	51%	94%
Free Cash Flow	1,005	740	836	908	1,055	842
Free Cash Flow Per Share	1.15	0.85	0.96	1.04	1.21	1.05
Gross Margin	26%	33.98%	38.52%	39.63%	43.54%	47.43%
Operating Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Profit Margin	9.32%	6.13%	27.41%	28.31%	55.13%	54.79%
Free Cash Flow Margin	15.31%	11.2%	11.32%	12.81%	20.23%	26.37%
EBITDA	--	1,241	1,838	1,889	1,500	1,013
EBITDA Margin	--	18.79%	24.89%	26.66%	28.77%	31.73%
D&A For EBITDA	--	152	126	110	71	57
EBIT	531	1,089	1,712	1,779	1,429	956
EBIT Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Effective Tax Rate	20.37%	32.53%	13.58%	12.1%	7.92%	8.52%

Hangzhou Tigermed Consulting Co Ltd (HNGZY) Price

HNGZY Stock Price Chart

HNGZY Income

Follow-Up Questions